R2D2-MH at a glance
Consortium partners
associations representing individuals with NDD
Countries
ACRONYM: R2D2-MH
Project title: Risk and Resilience in Developmental Diversity and Mental Health
Start Date: September 1, 2022
Project Duration: 60 months
EU contribution: € 7 856 507,50
Grant Agreement Number: 101057385
Coordinator: Prof. Thomas Bourgeron (Institut Pasteur, France)
The R2D2-MH consortium gathers partners from thirteen different countries Worldwide: Belgium, Denmark, France, Germany, Ireland, Italy, Spain, Sweden, Switzerland, the United Kingdom, The Netherlands for the European continent, as well as Australia (upper box) and Israel (lower box).
Ambitions of the R2D2-MH project
R2D2-MH will go beyond the state of the art by applying a highly interdisciplinary approach integrating diverse expertise: ethics, epidemiology, sociology, genetics, cell biology, neuroscience, computational modelling, IT development, psychology, and psychiatry. Our research is highly engaged: individuals with NDDs and their families are involved in research to ensure that our expected outcomes are truly translational. R2D2-MH will communicate through a strong dissemination strategy that includes a platform to discuss all R2D2-MH results with the stakeholder community and contribute to new policies via white papers pointing out gaps, needs and actions necessary to improve MH strategy and policy. R2D2-MH has four main ambitions to progress beyond the state of the art:
Ambition 1
Increase participatory research/medicine and reduce stigma surrounding mental health
Ambition 3
Provide the largest European multi-scale dataset on early brain and mental health diversity in humans
Ambition 2
Co-develop a first generation of predictive models for developmental diversities (co-creation)
Ambition 4
Identify biological mechanisms of resilience associated with diverse outcomes in developmental diversities